Genetic association of recovery from eating disorders

The role of GABA receptor SNPs

Cinnamon S. Bloss, Wade Berrettini, Andrew W. Bergen, Pierre Magistretti, Vikas Duvvuri, Michael Strober, Harry Brandt, Steve Crawford, Scott Crow, Manfred M. Fichter, Katherine A. Halmi, Craig Johnson, Allan S. Kaplan, Pamela Keel, Kelly L. Klump, James Mitchell, Janet Treasure, D. Blake Woodside, Enrica Marzola, Nicholas J. Schork & 1 others Walter H. Kaye

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Follow-up studies of eating disorders (EDs) suggest outcomes ranging from recovery to chronic illness or death, but predictors of outcome have not been consistently identified. We tested 5151 single-nucleotide polymorphisms (SNPs) in approximately 350 candidate genes for association with recovery from ED in 1878 women. Initial analyses focused on a strictly defined discovery cohort of women who were over age 25 years, carried a lifetime diagnosis of an ED, and for whom data were available regarding the presence (n=361 ongoing symptoms in the past year, ie, ill) or absence (n=115 no symptoms in the past year, ie, recovered) of ED symptoms. An intronic SNP (rs17536211) in GABRG1 showed the strongest statistical evidence of association (p=4.63 × 10 -6 , false discovery rate (FDR)=0.021, odds ratio (OR)=0.46). We replicated these findings in a more liberally defined cohort of women age 25 years or younger (n=464 ill, n=107 recovered; p=0.0336, OR=0.68; combined sample p=4.57 × 10 -6 , FDR=0.0049, OR=0.55). Enrichment analyses revealed that GABA (γ-aminobutyric acid) SNPs were over-represented among SNPs associated at p=0.05 in both the discovery (Z=3.64, p=0.0003) and combined cohorts (Z=2.07, p=0.0388). In follow-up phenomic association analyses with a third independent cohort (n=154 ED cases, n=677 controls), rs17536211 was associated with trait anxiety (p=0.049), suggesting a possible mechanism through which this variant may influence ED outcome. These findings could provide new insights into the development of more effective interventions for the most treatment-resistant patients.

Original languageEnglish (US)
Pages (from-to)2222-2232
Number of pages11
JournalNeuropsychopharmacology
Volume36
Issue number11
DOIs
StatePublished - Oct 1 2011

Fingerprint

GABA Receptors
Single Nucleotide Polymorphism
Odds Ratio
Aminobutyrates
gamma-Aminobutyric Acid
Feeding and Eating Disorders
Chronic Disease
Anxiety
Genes

Keywords

  • GABA
  • anorexia nervosa
  • eating/metabolic disorders
  • genetic association
  • recovery from eating disorders
  • single nucleotide polymorphisms

Cite this

Bloss, C. S., Berrettini, W., Bergen, A. W., Magistretti, P., Duvvuri, V., Strober, M., ... Kaye, W. H. (2011). Genetic association of recovery from eating disorders: The role of GABA receptor SNPs. Neuropsychopharmacology, 36(11), 2222-2232. https://doi.org/10.1038/npp.2011.108

Genetic association of recovery from eating disorders : The role of GABA receptor SNPs. / Bloss, Cinnamon S.; Berrettini, Wade; Bergen, Andrew W.; Magistretti, Pierre; Duvvuri, Vikas; Strober, Michael; Brandt, Harry; Crawford, Steve; Crow, Scott; Fichter, Manfred M.; Halmi, Katherine A.; Johnson, Craig; Kaplan, Allan S.; Keel, Pamela; Klump, Kelly L.; Mitchell, James; Treasure, Janet; Woodside, D. Blake; Marzola, Enrica; Schork, Nicholas J.; Kaye, Walter H.

In: Neuropsychopharmacology, Vol. 36, No. 11, 01.10.2011, p. 2222-2232.

Research output: Contribution to journalArticle

Bloss, CS, Berrettini, W, Bergen, AW, Magistretti, P, Duvvuri, V, Strober, M, Brandt, H, Crawford, S, Crow, S, Fichter, MM, Halmi, KA, Johnson, C, Kaplan, AS, Keel, P, Klump, KL, Mitchell, J, Treasure, J, Woodside, DB, Marzola, E, Schork, NJ & Kaye, WH 2011, 'Genetic association of recovery from eating disorders: The role of GABA receptor SNPs', Neuropsychopharmacology, vol. 36, no. 11, pp. 2222-2232. https://doi.org/10.1038/npp.2011.108
Bloss CS, Berrettini W, Bergen AW, Magistretti P, Duvvuri V, Strober M et al. Genetic association of recovery from eating disorders: The role of GABA receptor SNPs. Neuropsychopharmacology. 2011 Oct 1;36(11):2222-2232. https://doi.org/10.1038/npp.2011.108
Bloss, Cinnamon S. ; Berrettini, Wade ; Bergen, Andrew W. ; Magistretti, Pierre ; Duvvuri, Vikas ; Strober, Michael ; Brandt, Harry ; Crawford, Steve ; Crow, Scott ; Fichter, Manfred M. ; Halmi, Katherine A. ; Johnson, Craig ; Kaplan, Allan S. ; Keel, Pamela ; Klump, Kelly L. ; Mitchell, James ; Treasure, Janet ; Woodside, D. Blake ; Marzola, Enrica ; Schork, Nicholas J. ; Kaye, Walter H. / Genetic association of recovery from eating disorders : The role of GABA receptor SNPs. In: Neuropsychopharmacology. 2011 ; Vol. 36, No. 11. pp. 2222-2232.
@article{fe6716a01e594cf9ba1ddbed4ef8dc55,
title = "Genetic association of recovery from eating disorders: The role of GABA receptor SNPs",
abstract = "Follow-up studies of eating disorders (EDs) suggest outcomes ranging from recovery to chronic illness or death, but predictors of outcome have not been consistently identified. We tested 5151 single-nucleotide polymorphisms (SNPs) in approximately 350 candidate genes for association with recovery from ED in 1878 women. Initial analyses focused on a strictly defined discovery cohort of women who were over age 25 years, carried a lifetime diagnosis of an ED, and for whom data were available regarding the presence (n=361 ongoing symptoms in the past year, ie, ill) or absence (n=115 no symptoms in the past year, ie, recovered) of ED symptoms. An intronic SNP (rs17536211) in GABRG1 showed the strongest statistical evidence of association (p=4.63 × 10 -6 , false discovery rate (FDR)=0.021, odds ratio (OR)=0.46). We replicated these findings in a more liberally defined cohort of women age 25 years or younger (n=464 ill, n=107 recovered; p=0.0336, OR=0.68; combined sample p=4.57 × 10 -6 , FDR=0.0049, OR=0.55). Enrichment analyses revealed that GABA (γ-aminobutyric acid) SNPs were over-represented among SNPs associated at p=0.05 in both the discovery (Z=3.64, p=0.0003) and combined cohorts (Z=2.07, p=0.0388). In follow-up phenomic association analyses with a third independent cohort (n=154 ED cases, n=677 controls), rs17536211 was associated with trait anxiety (p=0.049), suggesting a possible mechanism through which this variant may influence ED outcome. These findings could provide new insights into the development of more effective interventions for the most treatment-resistant patients.",
keywords = "GABA, anorexia nervosa, eating/metabolic disorders, genetic association, recovery from eating disorders, single nucleotide polymorphisms",
author = "Bloss, {Cinnamon S.} and Wade Berrettini and Bergen, {Andrew W.} and Pierre Magistretti and Vikas Duvvuri and Michael Strober and Harry Brandt and Steve Crawford and Scott Crow and Fichter, {Manfred M.} and Halmi, {Katherine A.} and Craig Johnson and Kaplan, {Allan S.} and Pamela Keel and Klump, {Kelly L.} and James Mitchell and Janet Treasure and Woodside, {D. Blake} and Enrica Marzola and Schork, {Nicholas J.} and Kaye, {Walter H.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1038/npp.2011.108",
language = "English (US)",
volume = "36",
pages = "2222--2232",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Genetic association of recovery from eating disorders

T2 - The role of GABA receptor SNPs

AU - Bloss, Cinnamon S.

AU - Berrettini, Wade

AU - Bergen, Andrew W.

AU - Magistretti, Pierre

AU - Duvvuri, Vikas

AU - Strober, Michael

AU - Brandt, Harry

AU - Crawford, Steve

AU - Crow, Scott

AU - Fichter, Manfred M.

AU - Halmi, Katherine A.

AU - Johnson, Craig

AU - Kaplan, Allan S.

AU - Keel, Pamela

AU - Klump, Kelly L.

AU - Mitchell, James

AU - Treasure, Janet

AU - Woodside, D. Blake

AU - Marzola, Enrica

AU - Schork, Nicholas J.

AU - Kaye, Walter H.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Follow-up studies of eating disorders (EDs) suggest outcomes ranging from recovery to chronic illness or death, but predictors of outcome have not been consistently identified. We tested 5151 single-nucleotide polymorphisms (SNPs) in approximately 350 candidate genes for association with recovery from ED in 1878 women. Initial analyses focused on a strictly defined discovery cohort of women who were over age 25 years, carried a lifetime diagnosis of an ED, and for whom data were available regarding the presence (n=361 ongoing symptoms in the past year, ie, ill) or absence (n=115 no symptoms in the past year, ie, recovered) of ED symptoms. An intronic SNP (rs17536211) in GABRG1 showed the strongest statistical evidence of association (p=4.63 × 10 -6 , false discovery rate (FDR)=0.021, odds ratio (OR)=0.46). We replicated these findings in a more liberally defined cohort of women age 25 years or younger (n=464 ill, n=107 recovered; p=0.0336, OR=0.68; combined sample p=4.57 × 10 -6 , FDR=0.0049, OR=0.55). Enrichment analyses revealed that GABA (γ-aminobutyric acid) SNPs were over-represented among SNPs associated at p=0.05 in both the discovery (Z=3.64, p=0.0003) and combined cohorts (Z=2.07, p=0.0388). In follow-up phenomic association analyses with a third independent cohort (n=154 ED cases, n=677 controls), rs17536211 was associated with trait anxiety (p=0.049), suggesting a possible mechanism through which this variant may influence ED outcome. These findings could provide new insights into the development of more effective interventions for the most treatment-resistant patients.

AB - Follow-up studies of eating disorders (EDs) suggest outcomes ranging from recovery to chronic illness or death, but predictors of outcome have not been consistently identified. We tested 5151 single-nucleotide polymorphisms (SNPs) in approximately 350 candidate genes for association with recovery from ED in 1878 women. Initial analyses focused on a strictly defined discovery cohort of women who were over age 25 years, carried a lifetime diagnosis of an ED, and for whom data were available regarding the presence (n=361 ongoing symptoms in the past year, ie, ill) or absence (n=115 no symptoms in the past year, ie, recovered) of ED symptoms. An intronic SNP (rs17536211) in GABRG1 showed the strongest statistical evidence of association (p=4.63 × 10 -6 , false discovery rate (FDR)=0.021, odds ratio (OR)=0.46). We replicated these findings in a more liberally defined cohort of women age 25 years or younger (n=464 ill, n=107 recovered; p=0.0336, OR=0.68; combined sample p=4.57 × 10 -6 , FDR=0.0049, OR=0.55). Enrichment analyses revealed that GABA (γ-aminobutyric acid) SNPs were over-represented among SNPs associated at p=0.05 in both the discovery (Z=3.64, p=0.0003) and combined cohorts (Z=2.07, p=0.0388). In follow-up phenomic association analyses with a third independent cohort (n=154 ED cases, n=677 controls), rs17536211 was associated with trait anxiety (p=0.049), suggesting a possible mechanism through which this variant may influence ED outcome. These findings could provide new insights into the development of more effective interventions for the most treatment-resistant patients.

KW - GABA

KW - anorexia nervosa

KW - eating/metabolic disorders

KW - genetic association

KW - recovery from eating disorders

KW - single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=80052733666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052733666&partnerID=8YFLogxK

U2 - 10.1038/npp.2011.108

DO - 10.1038/npp.2011.108

M3 - Article

VL - 36

SP - 2222

EP - 2232

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 11

ER -